iQIYI Extends Theatrical Film Value with Cross-Platform Success of "The Shadow's Edge"
BEIJING, Nov. 28, 2025 /PRNewswire/ -- Recently, iQIYI, China's leading online entertainment platform, announced the successful online release of its action-crime thriller "The Shadow's Edge", which quickly achieved top rankings and strong viewer...
Weihai Receives National Award for Excellence in Accessibility Development
BEIJING, Nov. 28, 2025 /PRNewswire/ -- A news report from CRI Online: Weihai has been recognized as an "Outstanding Contributor in Accessibility and Age-Friendly Renovation" for its achievements in building an inclusive urban environment. The award...
JETOUR Partners with Discovery and CCF to Relaunch the "Return of the Cheetah"
WUHU, China, Nov. 28, 2025 /PRNewswire/ -- Following the global success of the environmental documentary Return of the Cheetah, JETOUR has once again joined hands with Discovery Channel and the Cheetah Conservation Fund (CCF) to relaunch the "Return...
Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours
Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid...
JMGO Advances North American Market Strategy Through New Presence on Costco
SHENZHEN, China, Nov. 28, 2025 /PRNewswire/ -- JMGO, a pioneer in optical technology, announced its official cooperation with Costco in North America. Currently, JMGO has entered Costco Canada and will enter Costco USA by the end of this year,...
Weihai Emerges as Sought-After Destination Wedding City
BEIJING, Nov. 28, 2025 /PRNewswire/ -- A news report from CRI Online: As sapphire seas and skies become the backdrop for "I dos" and cityscapes blend into sweet ceremonies, destination weddings are emerging as a new trend among young couples....
The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma
CHENGDU, China, Nov. 28, 2025 /PRNewswire/ -- Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or metastatic...
Weihai Launches Pioneering Reforms for Business Name Registration
BEIJING, Nov. 28, 2025 /PRNewswire/ -- A news report from CRI Online: Weihai has introduced two new regulatory documents: the "Weihai Guidelines for Enterprise Name Registration Management" and the "Weihai Implementation Rules for Enterprise Name...